Related Experiment Video
Updated: Jan 22, 2026
16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
13.2K
Massive hepatic necrosis-associated acute liver failure.
Tao Lin1, Chenhao Tong1,2, Roman Liebe3
1Department of Medicine II, Section Molecular Hepatology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Egastroenterology
|January 21, 2026
Summary
Massive hepatic necrosis (MHN) causes severe acute liver failure (ALF) with high mortality. Liver regeneration in MHN-associated ALF relies on liver progenitor cells (LPCs), crucial for patient outcomes.
Area of Science:
- Hepatology
- Pathology
- Regenerative Medicine
Background:
- Massive hepatic necrosis (MHN) is the most severe liver lesion in acute liver failure (ALF).
- MHN-associated ALF has a higher mortality rate compared to other ALF causes.
- Viral hepatitis (A, B, E), autoimmune hepatitis, and drug toxicity are common MHN-associated ALF triggers.
Purpose of the Study:
- To review the pathophysiology of MHN-associated ALF.
- To discuss recent advances in liver progenitor cell (LPC) biology.
- To highlight the role of LPCs in liver regeneration and clinical outcomes in MHN-associated ALF.
Main Methods:
- Literature review of pathophysiology and LPC biology.
- Analysis of clinical outcomes in MHN-associated ALF.
- Synthesis of current research on liver regeneration mechanisms.
Main Results:
- MHN-associated ALF is characterized by extensive hepatocyte loss.
- Liver regeneration in MHN-associated ALF is dependent on liver progenitor cells (LPCs).
- LPCs are critical for determining patient outcomes in severe acute liver injury.
Conclusions:
- Understanding MHN-associated ALF pathophysiology is vital for improving patient survival.
- LPC biology offers potential therapeutic targets for enhancing liver regeneration.
- Further research into LPCs is essential for managing severe acute liver failure.
Related Concept Videos
01:21Acute Respiratory Failure-I
901
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
901
01:21Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
01:29Acute Respiratory Failure-V
476
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
476
01:30Acute Respiratory Failure-III
811
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
811
01:23Acute Respiratory Failure-IV
526
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
526
01:16Necrosis
6.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.4K